- RecruitingPHASE2
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
This study looks at a new inhaled medicine, SNG001, for people in intensive care with severe breathing problems from a viral infection. We want to see if it's safe and helps them get better faster, compared to usual care.
For: Viral PneumoniaUnited States · Belgium · France - Ongoing, recruitingTherapeutic exploratory (Phase II)
A phase 2, two-part study to assess the safety, antiviral biomarker responses, and efficacy of inhaled SNG001 for the treatment of patients with a confirmed respiratory virus infection undergoing invasive mechanical ventilation
This study is looking at a new inhaled medicine, SNG001, for people in hospital with lung infections caused by viruses. We want to see if it's safe, helps the body fight the virus, and improves recovery for those needing breathing support.
For: Lower respiratory tract viral infectionsNetherlands · France · Spain